In August 2023, the Ministry of Health & Family Welfare issued revised guidelines for the issuance of anti-cancer medicines under the Central Government Health Scheme (CGHS).
Revised guidelines for issuance of Anti-Cancer Medicines in CGHS
Z15025/21/2023/DIR/CGHS
1/3611010/2023
F. No. Z 25015/21/2023/DIR/CGHS
Min. of Health & Family Welfare
Directorate of CGHS
CGHS Bhawan
Sector -13, RK puram, New Delhi.110066
Dated: August, 2023
OFFICE MEMORANDUM
Subject: Revised guidelines for issuance of Anti-Cancer Medicines in CGHS regarding
With reference to the above subject, the undersigned is directed to convey the approval of the Competent Authority to issue revised guidelines for the approval of anti-cancer medicines to CGHS beneficiaries as per the details given below:
I) In respect of non-Imported ofline And-cancer medicines, advised by a Specialist of Govt. Hospital/empanelled hospital approval shall be granted as per the delails given as under:
a. If the cost of medicines is less than Rs. 1,00,000/-. for one chemotherapy cycle. It shall be approved by the Addl. Director, CGHS without the requirement of examination by STC., for a maximum of 3 cycles. Meanwhile, an STC examination may be carried out.
b). If the cost of medicines is between Rs.1,00,00 to Rs. 1.50.000/- for one chemotherapy cycle. It shall be approved by the Director, CGHS without the requirement of examination by STC for a maximum of 3 cycles. Meanwhile, STC examination may be carried out.
C. In case the cost of medicines is more than Rs. 1.50.000/- for one chemotherapy cycle. the cases shall be placed before the STC of experts for jostificaton. before seeking the approval of the Competent Authonty.
d. Once, a perticular drug for chemotherapy for an individual beneficiary has been approved, on the recommendation of STC, no further STC approval shall be needed for further continuation of treatment, provided the same treatment is continued.
II) In respect of imported anti-cancer medicines the existing guidelines would continue as follows:
“The medicine which has been advised by Govt. Specialists / Specialists of Empaneled hospitals shall be placed before the STC of Experts and if the medicine is justified, approval Of Competent Authority and concerrence of IFDshall be soficiated. After the approval of the Competent authority, an indent for such medicines shall be placed with the Embassy/ High Commisson of the concerned country tor procurement”
Signed by
Manoj Jain
